Muna Therapeutics attracts $73m Series A

Muna Therapeutics, a developer of small molecule therapeutics for neurodegenerative diseases, has raised $73 million in Series A funding.

Muna Therapeutics, a developer of small molecule therapeutics for neurodegenerative diseases, has raised $73 million in Series A funding. Novo Holdings, Sofinnova Partners, Droia Ventures and LSP Dementia Fund led the round with participation from Polaris Partners, Polaris Innovation Fund, Sanofi Ventures, V-Bio Ventures and VIB.

Source: Press Release